Shamir Geller is a Dermatology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 132 publications with 1,456 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
530 E 74th St
New York, NY 100213459
Telephone
646-608-2301Provider last certified this registry record 6 Feb 2023.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Secura Bio, Inc.Program year20251 payment
- KYOWA KIRIN, INC.Program year20251 payment
- Kyowa Kirin, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
35.9%Corticosteroid27.7%Triamcinolone Acetonide91%Fluocinolone Acetonide9%Part D<11 patientsalpha-Hydroxy Acid5.3%Ammonium Lactate100%Part D≥11 patients+ 1 more class in this area
Sensory organs
31.6%Corticosteroid31.6%Clobetasol Propionate81%Hydrocortisone12%Betamethasone Dipropionate8%Part D<11 patientsRespiratory
16.4%RNA Synthetase Inhibitor Antibacterial13.7%Mupirocin100%Part D≥39 patientsCorticosteroid2.7%Mometasone Furoate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and Recommendations
American Journal of Clinical Dermatology
2025 - Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System
Journal of Investigative Dermatology
2024 - Cutaneous T‐cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
Journal of the European Academy of Dermatology and Venereology
2024 - Racial Disparities in Mycosis Fungoides/Sézary Syndrome–A Single-Center Observational Study of 292 Patients
Clinical Lymphoma Myeloma & Leukemia
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”